Holen Sie sich die Stockscreener-App
4.05
1.22%
-0.05
Handel nachbörslich:
4.11
0.06
+1.48%
Schlusskurs vom Vortag:
$4.10
Offen:
$4.09
24-Stunden-Volumen:
64,487
Relative Volume:
0.30
Marktkapitalisierung:
$38.26M
Einnahmen:
$5.12M
Nettoeinkommen (Verlust:
$-67.00M
KGV:
-2.7551
EPS:
-1.47
Netto-Cashflow:
$-38.94M
1W Leistung:
-12.15%
1M Leistung:
-14.74%
6M Leistung:
-26.75%
1J Leistung:
-71.48%
1-Tages-Spanne:
$3.9458
$4.15
1-Wochen-Bereich:
$3.9458
$4.8498
52-Wochen-Spanne:
$3.816
$17.38
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Firmenname
Verrica Pharmaceuticals Inc
Sektor
Branche
Telefon
484-453-3300
Adresse
10 NORTH HIGH STREET, WEST CHESTER, PA
Vergleichen Sie VRCA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
4.05 | 38.73M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-06 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-25 | Hochstufung | Needham | Hold → Buy |
| 2023-03-22 | Eingeleitet | Jefferies | Buy |
| 2023-02-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-05-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-24 | Eingeleitet | Northland Capital | Outperform |
| 2020-03-24 | Eingeleitet | Needham | Buy |
| 2019-02-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten
Is Verrica Pharmaceuticals Inc. stock positioned for digital transformationRisk Management & Reliable Volume Spike Trade Alerts - newser.com
Is this a good reentry point in Verrica Pharmaceuticals Inc.Earnings Recap Report & Low Risk Entry Point Tips - newser.com
Can Verrica Pharmaceuticals Inc. rally from current levelsWeekly Gains Summary & Growth Oriented Trading Recommendations - newser.com
What to do if you’re stuck in Verrica Pharmaceuticals Inc.Trade Signal Summary & Safe Capital Allocation Plans - newser.com
Will Verrica Pharmaceuticals Inc. stock rally after Fed decisionsWeekly Gains Summary & Daily Stock Trend Watchlist - newser.com
Short interest data insights for Verrica Pharmaceuticals Inc.Portfolio Growth Summary & High Conviction Buy Zone Picks - newser.com
Why Verrica Pharmaceuticals Inc. (1NE) stock remains top ratedIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Technical signs of recovery in Verrica Pharmaceuticals Inc.July 2025 Trade Ideas & Capital Efficient Trading Techniques - newser.com
Verrica Pharmaceuticals to Present Phase 2 Data on VP-315 at Major Immunotherapy Conference - MyChesCo
Is Verrica Pharmaceuticals Inc. stock poised for growth2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
How to recover losses in Verrica Pharmaceuticals Inc. stockJuly 2025 Momentum & Consistent Profit Alerts - newser.com
Published on: 2025-10-10 09:59:41 - newser.com
Published on: 2025-10-09 06:44:03 - newser.com
Smart tools for monitoring Verrica Pharmaceuticals Inc.’s price action2025 Market Trends & Low Risk High Win Rate Stock Picks - newser.com
What analysts say about Verrica Pharmaceuticals Inc stockMarket Breadth Indicators & High Return Portfolio Growth - earlytimes.in
Verrica Pharmaceuticals to Present VP-315 Data at SITC 40th Annual Meeting for Basal Cell Carcinoma Treatment - Quiver Quantitative
Verrica Pharmaceuticals to Present New Data on VP-315 from - GlobeNewswire
12‑Week Immune Activation: Verrica Presents Phase 2 VP-315 Tumor Microenvironment Data at SITC - Stock Titan
What drives Verrica Pharmaceuticals Inc stock priceResistance Zone Identification & Machine Learning Stock Picks, Daily - earlytimes.in
Why analysts raise outlook for Verrica Pharmaceuticals Inc. (1NE) stockGap Up & Risk Adjusted Swing Trade Ideas - newser.com
What drives Verrica Pharmaceuticals Inc 1NE stock priceDouble Top/Bottom Patterns & Superior Capital Trading Plans - earlytimes.in
Published on: 2025-10-05 07:16:48 - newser.com
What makes Verrica Pharmaceuticals Inc. (1NE) stock appealing to growth investorsRate Cut & Weekly High Potential Stock Alerts - newser.com
Risk adjusted return profile for Verrica Pharmaceuticals Inc. analyzed2025 Analyst Calls & Real-Time Chart Breakout Alerts - newser.com
News impact scoring models applied to Verrica Pharmaceuticals Inc.July 2025 Drop Watch & Long Hold Capital Preservation Tips - newser.com
Using data tools to time your Verrica Pharmaceuticals Inc. exitJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
Will Verrica Pharmaceuticals Inc. (1NE) stock justify high valuationJuly 2025 Catalysts & Safe Capital Investment Plans - newser.com
Why Verrica Pharmaceuticals Inc. (1NE) stock stays on top picksQuarterly Trade Review & Consistent Income Trade Ideas - newser.com
Is Verrica Pharmaceuticals (NASDAQ:VRCA) Weighed On By Its Debt Load? - 富途牛牛
What technical models suggest about Verrica Pharmaceuticals Inc.’s comebackJuly 2025 Summary & Low Risk High Reward Ideas - newser.com
How to build a dashboard for Verrica Pharmaceuticals Inc. stock2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Does Verrica Pharmaceuticals Inc. fit your quant trading modelRecession Risk & Weekly Chart Analysis and Guides - newser.com
Is Verrica Pharmaceuticals Inc. (1NE) stock a safe buy pre earningsMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Earnings visualization tools for Verrica Pharmaceuticals Inc.July 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Goldman Sachs Group Inc. Boosts Stake in Verrica Pharmaceuticals Inc. $VRCA - Defense World
Published on: 2025-10-01 07:41:33 - newser.com
Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):